GLAXOSMITHKLINE PHARMA A/S — Credit Rating and Financial Key Figures

GLAXOSMITHKLINE PHARMA A/S (CVR number: 27394019) is a company from VALLENSBÆK. The company reported a net sales of 548.5 mDKK in 2024, demonstrating a growth of 15.6 % compared to the previous year. The operating profit percentage was at 3 % (EBIT: 16.6 mDKK), while net earnings were 12.2 mDKK. The profitability of the company measured by Return on Assets (ROA) was 15.6 %, which can be considered excellent and Return on Equity (ROE) was 32.2 %, which can be considered excellent. The equity ratio, a key indicator for solidity, stood at 38.5 %, a level that can be considered to be low. This means a higher proportion of debt in its capital structure, indicating a greater reliance on borrowed funds. GLAXOSMITHKLINE PHARMA A/S's liquidity measured by quick ratio was 1.6 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.